ישראל - עברית - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - טבליות בשחרור ממושך - oxycodone hydrochloride 5 mg; naloxone hydrochloride (as dihydrate) 2.5 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - טבליות בשחרור ממושך - naloxone hydrochloride (as dihydrate) 20 mg; oxycodone hydrochloride 40 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut

ישראל - עברית - Ministry of Health

j-c health care ltd - trolamine - קרם - trolamine 0.67 %w/w - soothes burns, sunburns, sores and wounds.

ישראל - עברית - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride; glucose; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.4 g/l; magnesium chloride 0.051 g/l; calcium chloride 0.184 g/l; glucose as monohydrate 15 g/l; glucose 13.6 g/l; lactic acid as sodium 4.5 g/l - isotonic solutions - for peritoneal dialysis including acute and chronic renal failure, severe water retention, electrolyte disorders, drug intoxication.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - varicella virus, live attenuated - אבקה וממס להכנת תמיסה להזרקה - varicella virus, live attenuated nlt 10^3.3 pfu - varicella zoster vaccines - in the event of negative anamnesis, for the active immunisation against varicella in healthy subjects only from the age of 12 months.

ישראל - עברית - Ministry of Health

promedico ltd - citric acid anhydrous; simethicone; sodium bicarbonate - גרנולות תוססות - citric acid anhydrous 38.21 %w/w; simethicone 1 %w/w; sodium bicarbonate 55.14 %w/w - electrolyte solutions - for the relief of heartburn sour stomach acid indigestion upset stomach and gas associated with these symptoms. for use only in x-ray departments: endoscopic adjunct. is indicated as an adjunct to contrast media utilized during a double - contrast upper gastro-intestinal (dcugi) examination.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 5 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 10 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.